Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-α
- 6 February 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 341 (8841) , 372
- https://doi.org/10.1016/0140-6736(93)90172-d
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Residual acute confusional and hallucinatory syndromes induced by interleukin‐2/α‐interferon treatmentPsycho‐Oncology, 1992
- Interleukin-2 toxicity.Journal of Clinical Oncology, 1991
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- The effect of intravenous interleukin-2 on brain water contentJournal of Neurosurgery, 1989
- The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1987